Cytomegalovirus in Hematopoietic Stem Cell Transplant Recipients

被引：119

作者：

Ljungman, Per ^{[1
,2
]}

Hakki, Morgan ^{[3
]}

Boeckh, Michael ^{[4
,5
]}

机构：

[1] Karolinska Inst, Dept Med Huddinge, Div Hematol, S-14186 Stockholm, Sweden

[2] Karolinska Univ Hosp, Dept Hematol, S-14186 Huddinge, Sweden

[3] Oregon Hlth & Sci Univ, Div Infect Dis, Portland, OR 97201 USA

[4] Univ Washington, Seattle, WA 98195 USA

[5] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Inst, Seattle, WA 98109 USA

来源：

INFECTIOUS DISEASE CLINICS OF NORTH AMERICA | 2010年 / 24卷 / 02期

关键词：

Adoptive immunotherapy; Antiviral therapy; Cytomegalovirus; Hematopoietic stem cell transplantation; BONE-MARROW-TRANSPLANT; POLYMERASE-CHAIN-REACTION; VERSUS-HOST-DISEASE; INTRAVENOUS IMMUNE GLOBULIN; CORD BLOOD TRANSPLANTATION; PREEMPTIVE ANTIVIRAL THERAPY; CHRONIC MYELOID-LEUKEMIA; PERIPHERAL-BLOOD; RISK-FACTORS; CMV INFECTION;

D O I：

10.1016/j.idc.2010.01.008

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

This article examines the clinical manifestations of and risk factors for cytomegalovirus (CMV). Prevention of CMV infection and disease are also explored. Antiviral resistance and management of CMV are examined.

引用

页码：319 / +

页数：20

共 164 条

[1] Umbilical cord blood transplantation and cytomegalovirus: posttransplantation infection and donor screening [J].

Albano, Maria S. ;

Taylor, Patricia ;

Pass, Robert F. ;

Scaradavou, Andromachi ;

Ciubotariu, Rodica ;

Carrier, Carmelita ;

Dobrila, Ludy ;

Rubinstein, Pablo ;

Stevens, Cladd E. .

BLOOD, 2006, 108 (13) :4275-4282

[2] Valganciclovir as pre-emptive therapy for cytomegalovirus infection post-allogenic stem cell transplantation: implications for the emergence of drug-resistant cytomegalovirus [J].

Allice, Tiziano ;

Busca, Alessandro ;

Locatelli, Franco ;

Falda, Michele ;

Pittaluga, Fabrizia ;

Ghisetti, Valeria .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2009, 63 (03) :600-608

[3] A survey of allogeneic bone marrow transplant programs in the United States regarding cytomegalovirus prophylaxis and pre-emptive therapy [J].

Avery, RK ;

Adal, KA ;

Longworth, DL ;

Bolwell, BJ .

BONE MARROW TRANSPLANTATION, 2000, 26 (07) :763-767

[4] Use of leflunomide in an allogeneic bone marrow transplant recipient with refractory cytomegalovirus infection [J].

Avery, RK ;

Bolwell, BJ ;

Yen-Lieberman, B ;

Lurain, N ;

Waldman, WJ ;

Longworth, DL ;

Taege, AJ ;

Mossad, SB ;

Kohn, D ;

Long, JR ;

Curtis, J ;

Kalaycio, M ;

Pohlman, B ;

Williams, JW .

BONE MARROW TRANSPLANTATION, 2004, 34 (12) :1071-1075

[5] Evaluation of intervention strategy based on CMV-specific immune responses after allogeneic SCT [J].

Avetisyan, G. ;

Aschan, J. ;

Haegglund, H. ;

Ringden, O. ;

Ljungman, P. .

BONE MARROW TRANSPLANTATION, 2007, 40 (09) :865-869

[6] Valganciclovir is safe and effective as pre-emptive therapy for CMV infection in allogeneic hematopoietic stem cell transplantation [J].

Ayala, E ;

Greene, J ;

Sandin, R ;

Perkins, J ;

Field, T ;

Tate, C ;

Fields, KK ;

Goldstein, S .

BONE MARROW TRANSPLANTATION, 2006, 37 (09) :851-856

[7]

BASS E, 1993, BONE MARROW TRANSPL, V12, P179

[8] Leflunomide failure to control recurrent cytomegalovirus infection in the setting of renal failure after allogeneic stem cell transplantation [J].

Battiwalla, M. ;

Paplham, P. ;

Almyroudis, N. G. ;

McCarthy, A. ;

Abdelhalim, A. ;

Elefante, A. ;

Smith, P. ;

Becker, J. ;

McCarthy, P. L. ;

Segal, B. H. .

TRANSPLANT INFECTIOUS DISEASE, 2007, 9 (01) :28-32

[9] Donor and Recipient CMV Serostatus and Outcome of Pediatric Allogeneic HSCT for Acute Leukemia in the Era of CMV-Preemptive Therapy [J].

Behrendt, Carolyn E. ;

Rosenthal, Joseph ;

Bolotin, Ellen ;

Nakamura, Ryotaro ;

Zaia, John ;

Forman, Stephen J. .

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (01) :54-60

[10] Cytomegalovirus viremia, viruria and disease after autologous peripheral blood stem cell transplantation: no need for surveillance [J].

Bilgrami, S ;

Aslanzadeh, J ;

Feingold, JM ;

Bona, RD ;

Clive, J ;

Dorsky, D ;

Edwards, RL ;

Tutschka, PJ .

BONE MARROW TRANSPLANTATION, 1999, 24 (01) :69-73

← 1 2 3 4 5 6 7 8 9 10 →